ZhenFund — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications.
AI & Machine LearningBiotechDeep TechSeattle, US
George Ueda, Ph.D.(Chief Technology Officer, Co-Founder)James Lazarovits, Ph.D.(Chief Executive Officer, Co-Founder)James Lazarovits(Founder)inGeorge Ueda(Founder)in
Co-investorsCornucopian Capital ManagementMadrona Venture GroupGaorong CapitalGaorong VenturesGobi PartnersIDG Capital+1 more
Archon provides compliance services that accelerate the federal authorization process for software vendors selling to government agencies, reducing typical timelines and associated expenses.
CybersecurityGovTechSan Francisco, US
George Parks(Founder and CEO)in
Co-investorsY CombinatorGaorong CapitalGaorong VenturesGobi PartnersIDG CapitalRebel Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.